Vanguard Global Advisers’s Zymeworks ZYME Stock Holding History

Vanguard Global Advisers’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$143K	Hold	5,459	–	–	﹤0.01%	2638
2026 Q1	$137K	Buy	+5,459	New	+$129K	﹤0.01%	2595

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Vanguard Global Advisers's ZYME Position: Q2 2026 in Review

Vanguard Global Advisers held its Zymeworks (ZYME) position steady in Q2 2026 at 5,459 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #2638.

Vanguard Global Advisers first reported a position in ZYME in Q1 2026 and has held it in 2 quarters since. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

Vanguard Global Advisers held 5,459 shares of Zymeworks worth $143K as of Q2 2026.
Vanguard Global Advisers left its Zymeworks share count unchanged in Q2 2026.
Zymeworks made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2638 holding.
Vanguard Global Advisers first reported a position in Zymeworks in Q1 2026 and has held it in 2 quarters since.
202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.